These findings indicate that MLT, XYAS, LXJD, and QXAS could inhibit psoriasis-like inflammation to varying degrees by down-regulating the expression levels of IL-6, IL-17, and TNF-α. The gene discussed is IL17A; the disease is psoriasis.